Advancements in Bladder Cancer Treatment

This chapter explores groundbreaking findings from the EV302 study on bladder cancer, emphasizing the efficacy of N4-tamab combined with PEMBRO and its impact on progression-free and overall survival rates. It also discusses the transformative potential of new therapies, ongoing trials, and the importance of biomarker development in optimizing treatment strategies.